John Paul Secrist - Feb 22, 2022 Form 4 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Chief Scientific Officer
Signature
/s/ Andrew Gengos, Attorney-in-Fact
Stock symbol
CYT
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 03:57 PM
Previous filing
Jun 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYT Stock Option (Right to Buy) Award $0 +42K $0.00 42K Feb 22, 2022 Common Stock 42K $5.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments, subject to the Reporting Person's continued employment with the Company through the applicable vesting date.